Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Breast 1

Conditions

Thyroid Nodule 2Pain 2Carcinoma, Hepatocellular 2Breast Neoplasms 2Agnosia 2Prostatic Neoplasms 1Neuroma 1Neuralgia 1Neoplasm Metastasis 1Myoma 1Multiple Pulmonary Nodules 1Multiple Advanced Tumors After PD-1 Therapy Failure 1Menorrhagia 1Lymphoma, Follicular 1Lipoma 1Leiomyoma 1Hypesthesia 1Hyperthyroidism 1Hyperaldosteronism 1Esophageal Neoplasms 1Colorectal Neoplasms 1Cicatrix 1Carcinoma, Renal Cell 1Breast Cancer Female 1Bone Cancer Metastatic 1Barrett Esophagus 1Adenocarcinoma Of Esophagus 1Adenocarcinoma 1ACTH Syndrome, Ectopic 1

Interventions

Rituximab 53Cyclophosphamide 50Lenalidomide 41fludarabine 24obinutuzumab 23Prednisone 19Bendamustine Hydrochloride 19Magnetic Resonance Spectroscopy 18Vincristine 17Doxorubicin 16fludarabine phosphate 15Specimen Handling 15zanubrutinib 13Biopsy 12tazemetostat 10ibrutinib 10Whole-Body Irradiation 10pembrolizumab 9Peripheral Blood Stem Cell Transplantation 9venetoclax 8Mycophenolic Acid 7Etoposide 7axicabtagene ciloleucel 6Radiotherapy 6CT-P10 6Therapeutics 5R-CHOP protocol 5tafasitamab 4polatuzumab vedotin 4acalabrutinib 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, Follicular × Radiofrequency Ablation × 1 year × Clear all
NCT07206121 2026-02-11

Feasibility Study for the SIRA-1000, SIRA® RFA Electrosurgical Device as an Adjunct to Breast Conserving Surgery

Innoblative Designs, Inc.

Phase NA Recruiting
10 enrolled
BreastLymphoid

Breast Neoplasms, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡